Penumbra, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PEN research report →
Companywww.penumbrainc.com
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands.
- CEO
- Adam Elsesser
- IPO
- 2015
- Employees
- 4,500
- HQ
- Alameda, CA, US
Price Chart
Valuation
- Market Cap
- $12.88B
- P/E
- 75.17
- P/S
- 8.85
- P/B
- 8.72
- EV/EBITDA
- 60.44
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 67.38%
- Op Margin
- 12.87%
- Net Margin
- 11.76%
- ROE
- 12.32%
- ROIC
- 9.26%
Growth & Income
- Revenue
- $1.40B · 17.50%
- Net Income
- $177.69M · 1168.11%
- EPS
- $4.57 · 1169.44%
- Op Income
- $189.25M
- FCF YoY
- 18.76%
Performance & Tape
- 52W High
- $362.41
- 52W Low
- $221.26
- 50D MA
- $330.01
- 200D MA
- $300.51
- Beta
- 0.73
- Avg Volume
- 571.29K
Get TickerSpark's AI analysis on PEN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 2, 26 | Grewal Harpreet | sell | 100 |
| Mar 15, 26 | Narayan Shruthi | other | 117 |
| Mar 15, 26 | Roberts Johanna | other | 186 |
| Mar 15, 26 | Yuen Maggie | other | 186 |
| Mar 15, 26 | Shiu Lambert | other | 150 |
| Mar 2, 26 | Yuen Maggie | sell | 2,432 |
| Feb 13, 26 | Grewal Harpreet | other | 589 |
| Feb 13, 26 | Bose Arani | other | 589 |
| Feb 13, 26 | Leeds Janet | other | 589 |
| Feb 13, 26 | O'Rourke Bridget | other | 589 |
Our PEN Coverage
We haven't published any research on PEN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PEN Report →